The Edmonton Symptom Assessment System (ESAS) as a Screening Tool for Depression in Cancer Pain Patients

Screening Tool for Depresion in Cancer Pain Patients Clinical Trial

Official title:

The Edmonton Symptom Assessment System (ESAS) as a Screening Tool for Depression in Cancer Pain Patients

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT03686605
• Other study ID #: Si 276/2018
• Status: Completed
• Start date: September 24, 2018
• Est. completion date: January 31, 2020

Study information

• Verified date: July 2022
• Source: Mahidol University
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational [Patient Registry]

Clinical Trial Summary

Compare Thai versions of the Edmonton Symptom Assessment System (ESAS) and the Hospiral Anxiety and Depression Scale (HADS) with Diagnostic and Statistical Manual (DSM-5), as a screening tool for depression in cancer pain patients

Recruitment information / eligibility

• Status: Completed
• Enrollment: 49
• Est. completion date: January 31, 2020
• Est. primary completion date: December 31, 2019
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Cancer patients who follow up as out patient at pain clinic, Siriraj hospital
• Age older than 18 years old
• Fluently read, write and speak in Thai language
• No cognitive impairment

Exclusion Criteria:

• Unstable clinical presentation
• Severe pain or pain numerical rating scale more than 7
• Severe associated symptoms such as nausea, vomiting
• The patient who do not know their diagnosis

Related Conditions & MeSH terms

• Cancer Pain
• Screening Tool for Depresion in Cancer Pain Patients

Intervention

Other:
• Thai version of the Edmontom Symptom Assessment System (ESAS)
Screening and diagnostic questionaire for depression

Locations

Country	Name	City	State
Thailand	Faculty of medicine Siriraj Hospital Mahidol University	Bangkoknoi	Bangkok

Sponsors (1)

Lead Sponsor	Collaborator
Mahidol University

Country where clinical trial is conducted

Thailand, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Reliability and validity of Thai version of ESAS	Cut-off point, sensitivity, specificity, positive predictive value and negative predictive value of Thai version of ESAS	1 year
Secondary	Correlation of Thai version of ESAS, HADS and DSM-5	Pearson correlation, Sperman rank correlation	1 year
Secondary	Internal consistency of Thai version of ESAS and HADS	Cronbach's alpha	1 year